Pfizer’s sales over the review period 2012-2017 posted a CAGR of 5% that resulted in absolute global retail sales growth of USD1.4 billion, though Pfizer fell slightly in overall company ranking from fourth place to fifth in 2017 due to the Sanofi/Boehringer Ingelheim merger. Though Advil remains number one globally in analgesics, most of Pfizer’s portfolio growth occurred through the vitamin brand Centrum and dietary supplement brands Caltrate and Emergen-C.
You have no recently viewed reports.
Why not browse through our Featured or Trending Reports to see what we have to offer?
Euromonitor International's report on Pfizer Inc delivers a detailed strategic analysis of the company's business, examining its performance in the Vitamins and Dietary Supplements market and the global economy.
Company and market share data provide a detailed look at the financial position of Pfizer Inc, while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of Pfizer Inc.
Euromonitor International's company profile reports are written by our Vitamins and Dietary Supplements research team, a dedicated group of analysts that knows the industry inside and out.
Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.
Reports are delivered in PDF format and can be downloaded from your online account immediately after purchase.